Anglo-Norwegian healthcare group Nycomed is evaluating the structure of its Amersham Pharmacia Biotech unit, which is 45 percent owned by Pharmacia, Reuters reported.
According to the report, Nycomed CEO Bill Castell said that the company was considering increasing its stake in APB as well as floating the unit
An announcement on the new structure is expected soon.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
